Evaluation of DNA extracted from residual blood clots after serological testing
Cell Biochemistry and Function · 2024-06 · 42 (4)
DOI: 10.1002/cbf.4023 ↗At a glance
Journal article in Cell Biochemistry and Function, published online on 2024-04-26. Written by Shanshan Zhang and 6 co-authors. Institution: Hubei Key Laboratory of Urological Diseases, Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Zh…. Major MEDLINE topics: DNA. Cited 2 times so far (Crossref); 29 references. Funded by: The Fundamental Research Funds for the Central Universities, Research Fund of Zhongnan Hospital of Wuhan University.
Abstract (original language)
DNA quality is of paramount importance for molecular biology research. This study aimed to assess the DNA extracted from residual blood clots after serological testing, focusing on the impact of blood clot segments, extraction kits, temporary storage durations (TSDs), and thawing methods on DNA quality. We divided the residual blood clot column (BCC) from healthy donors into three segments and utilized two different extraction kits. The BCCs were subjected to four TSDs at 4°C (7 days, 10 days, 1 month, and 2 months) and three thawing methods (4°C, room temperature, and 37°C). We found that the TIANamp Blood Clot DNA Kit yielded consistently high‐quality DNA from each segment with stable A260/280 and A260/230 ratios. The DNA yield showed a strong positive correlation with leukocyte concentration, and a satisfactory median DNA yield of 28.79 μg/g BCC was obtained across all segments. DNA integrity, as measured by the DNA integrity number and DNA fragment peak size, decreased with increasing TSD at 4°C, with a notable decrease after 10 days of storage. Thawing at 37°C resulted in the lowest DNA fragment peak size. In conclusion, BCC could be an ideal DNA source with satisfactory yield and purity. A prolonged TSD at 4°C leads to an obvious decrease in DNA integrity, and thawing the frozen BCC at 37°C decreases DNA fragment sizes. To maintain DNA integrity, BCCs should be cryopreserved as soon as possible after short TSDs at 4°C and thawed at 4°C.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hubei Key Laboratory of Urological Diseases, Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Physical Examination Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Human Genetic Resources Preservation Center of Wuhan University, Wuhan, China.
- Laboratory of Precision Medicine, Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.
Funding
- The Fundamental Research Funds for the Central Universities
- Research Fund of Zhongnan Hospital of Wuhan University
Cite
APA
Zhang, S., Cheng, X., Yang, G., Peng, H., Zou, C., Yao, D., & Qian, K. (2024). Evaluation of DNA extracted from residual blood clots after serological testing. Cell Biochemistry and Function, 42(4). https://doi.org/10.1002/cbf.4023
Vancouver
Zhang S, Cheng X, Yang G, Peng H, Zou C, Yao D, et al. Evaluation of DNA extracted from residual blood clots after serological testing. Cell Biochemistry and Function. 2024;42(4). doi:10.1002/cbf.4023
BibTeX
@article{Zhang2024,
author = {Zhang, Shanshan and Cheng, Xiangqun and Yang, Gui and Peng, Hongwei and Zou, Cong and Yao, Dongai and Qian, Kaiyu},
title = {Evaluation of DNA extracted from residual blood clots after serological testing},
journal = {Cell Biochemistry and Function},
year = {2024},
volume = {42},
number = {4},
doi = {10.1002/cbf.4023}
}
EUVIMED